From the Department of Sunnybrook and Women's College Health Sciences Centre, Toronto, Canada (Dr. Gawel); University of Ulm, Ulm, Germany (Dr. Aschoff); University of Regensburg, Regensburg, Germany (Dr. May); and AstraZeneca, Macclesfield, UK (Mr. Charlesworth).
Zolmitriptan 5 mg Nasal Spray: Efficacy and Onset of Action in the Acute Treatment of Migraine—Results From Phase 1 of the REALIZE Study
Version of Record online: 22 DEC 2004
Headache: The Journal of Head and Face Pain
Volume 45, Issue 1, pages 7–16, January 2005
How to Cite
Gawel, M., Aschoff, J., May, A., Charlesworth, B. R. and REALIZE Study Team (2005), Zolmitriptan 5 mg Nasal Spray: Efficacy and Onset of Action in the Acute Treatment of Migraine—Results From Phase 1 of the REALIZE Study. Headache: The Journal of Head and Face Pain, 45: 7–16. doi: 10.1111/j.1526-4610.2005.05004.x
- Issue online: 22 DEC 2004
- Version of Record online: 22 DEC 2004
- Accepted for publication July 27, 2004
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.